The therapeutic potential of inhibitors of the signal transducer and activator of transcription 3 for central nervous system malignancies

Por Heimberger, Amy B.
Publicado em 2011

The PEP-3-KLH (CDX-110) vaccine in glioblastoma multiforme patients

Por Heimberger, Amy B., Sampson, John H
Publicado em 2009

Immunotherapy coming of age: What will it take to make it standard of care for glioblastoma?

Por Heimberger, Amy B., Sampson, John H.
Publicado em 2011

Immunosuppressive mechanisms in glioblastoma

Por Nduom, Edjah K., Weller, Michael, Heimberger, Amy B.
Publicado no Neuro Oncol (2015)

MicroRNAs as novel immunotherapeutics

Por Heimberger, Amy B, Gilbert, Mark, Rao, Ganesh, Wei, Jun
Publicado em 2013

Immunotherapy for Primary Brain Tumors: No Longer a Matter of Privilege

Por Fecci, Peter E., Heimberger, Amy B., Sampson, John H.
Publicado no Clin Cancer Res (2014)

Immunotherapy in glioblastoma: emerging options in precision medicine

Por Hodges, Tiffany R, Ferguson, Sherise D, Heimberger, Amy B
Publicado no CNS Oncol (2016)

The Role of Tregs in Glioma-Mediated Immunosuppression: Potential Target for Intervention

Por Humphries, William, Wei, Jun, Sampson, John H., Heimberger, Amy B.
Publicado em 2010

miRNA-mediated immune regulation and immunotherapeutic potential in glioblastoma

Por Jethwa, Krishan, Wei, Jun, McEnery, Kayla, Heimberger, Amy B
Publicado em 2011

Immune therapeutic targeting of glioma cancer stem cells

Por Hatiboglu, Mustafa Aziz, Wei, Jun, Wu, Adam, Heimberger, Amy B.
Publicado no Target Oncol (2010)

The natural history of EGFR and EGFRvIII in glioblastoma patients

Por Shi Weiming, Yang David, Suki Dima, Heimberger Amy B, Aldape Kenneth
Publicado em 2005-10-01

The natural history of EGFR and EGFRvIII in glioblastoma patients

Por Heimberger, Amy B, Suki, Dima, Yang, David, Shi, Weiming, Aldape, Kenneth
Publicado em 2005

Innate immune functions of microglia isolated from human glioma patients

Por Hussain, S Farzana, Yang, David, Suki, Dima, Grimm, Elizabeth, Heimberger, Amy B
Publicado em 2006

Clinical Applications of a Peptide-Based Vaccine for Glioblastoma

Por Kanaly, Charles W, Ding, Dale, Heimberger, Amy B., Sampson, John H
Publicado em 2010

The role of human glioma-infiltrating microglia/macrophages in mediating antitumor immune responses

Por Hussain, S. Farzana, Yang, David, Suki, Dima, Aldape, Kenneth, Grimm, Elizabeth, Heimberger, Amy B.
Publicado em 2006

MicroRNA-124 suppresses tumor cell proliferation and invasion by targeting CD164 signaling pathway in non-small cell lung cancer

Por Lin, Jing, Xu, Kai, Wei, Jun, Heimberger, Amy B, Roth, Jack A., Ji, Lin
Publicado no J Gene Ther (2016)

Tumor-specific Immunotherapy Targeting the EGFRvIII Mutation in Patients with Malignant Glioma

Por Sampson, John H., Archer, Gary E., Mitchell, Duane A., Heimberger, Amy B., Bigner, Darell D.
Publicado em 2008

Serum microRNA profiling in patients with glioblastoma: a survival analysis

Por Zhao, Hua, Shen, Jie, Hodges, Tiffany R., Song, Renduo, Fuller, Gregory N., Heimberger, Amy B.
Publicado no Mol Cancer (2017)

Metabolomics profiling in plasma samples from glioma patients correlates with tumor phenotypes

Por Zhao, Hua, Heimberger, Amy B., Lu, Zhimin, Wu, Xifeng, Hodges, Tiffany R., Song, Renduo, Shen, Jie
Publicado no Oncotarget (2016)

THE DUALITY OF FGL2 - SECRETED IMMUNE CHECKPOINT REGULATOR VERSUS MEMBRANE-ASSOCIATED PROCOAGULANT: THERAPEUTIC POTENTIAL AND IMPLICATIONS

Por Hu, Jiemiao, Yan, Jun, Rao, Ganesh, Latha, Khatri, Overwijk, Willem W., Heimberger, Amy B, Li, Shulin
Publicado no Int Rev Immunol (2014)